We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
–
AUM
$735M
AUM Growth
+$57.8M
Cap. Flow
+$11.1M
Cap. Flow %
1.5%
Top 10 Hldgs %
31.1%
Holding
195
New
10
Increased
148
Reduced
29
Closed
4

Top Buys

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$2.33M
2
AAPL icon
Apple
AAPL
+$1.25M
3
BE icon
Bloom Energy
BE
+$903K
4
MLPB icon
ETRACS Alerian MLP Infrastructure Index ETN Series B due Apr 2 2040
MLPB
+$552K
5
CRM icon
Salesforce
CRM
+$365K

Top Sells

Rank Stock Value
1
KNSA icon
Kiniksa Pharmaceuticals
KNSA
+$2.15M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$601K
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$576K
4
GLUU
Glu Mobile Inc.
GLUU
+$503K
5
MRNA icon
Moderna
MRNA
+$495K

Sector Composition

Rank Sector Weight
1 Technology 15.29%
2 Healthcare 12.02%
3 Consumer Staples 10.97%
4 Financials 10.35%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYRX icon
126
CryoPort
CYRX
$761M
$448K 0.06%
7,092
+1,154
+19% +$65K
TNDM icon
127
Tandem Diabetes Care
TNDM
$1.34B
$448K 0.06%
4,602
+567
+14% +$50.6K
ESTC icon
128
Elastic
ESTC
$6.84B
$447K 0.06%
3,067
+482
+19% +$60.2K
WDAY icon
129
Workday
WDAY
$39.6B
$444K 0.06%
1,861
+199
+12% +$47.9K
EVBG
130
DELISTED
Everbridge, Inc. Common Stock
EVBG
$441K 0.06%
3,241
+379
+13% +$47.4K
ETSY icon
131
Etsy
ETSY
$7.75B
$438K 0.06%
2,126
+248
+13% +$45.9K
PTON icon
132
Peloton Interactive
PTON
$2.77B
$426K 0.06%
3,438
+513
+18% +$54.6K
APPF icon
133
AppFolio
APPF
$6.38B
$420K 0.06%
2,972
+363
+14% +$50.4K
RGEN icon
134
Repligen
RGEN
$7.96B
$420K 0.06%
2,103
+234
+13% +$45.4K
RGNX icon
135
Regenxbio
RGNX
$620M
$416K 0.06%
10,702
+1,694
+19% +$60.6K
OKTA icon
136
Okta
OKTA
$24.7B
$411K 0.06%
1,680
+190
+13% +$45.9K
SAIL
137
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$411K 0.06%
8,038
+878
+12% +$42.2K
YEXT icon
138
Yext
YEXT
$547M
$403K 0.05%
28,193
+4,130
+17% +$57.5K
SRPT icon
139
Sarepta Therapeutics
SRPT
$1.57B
$401K 0.05%
5,159
+847
+20% +$64.2K
TENB icon
140
Tenable Holdings
TENB
$3.6B
$401K 0.05%
9,688
+1,418
+17% +$57.5K
INSP icon
141
Inspire Medical Systems
INSP
$1.45B
$400K 0.05%
2,070
+207
+11% +$41.1K
VRTX icon
142
Vertex Pharmaceuticals
VRTX
$121B
$399K 0.05%
1,979
+248
+14% +$51.9K
ALRM icon
143
Alarm.com
ALRM
$2.71B
$398K 0.05%
4,697
+567
+14% +$48.4K
BPMC
144
DELISTED
Blueprint Medicines
BPMC
$396K 0.05%
4,504
+545
+14% +$49.9K
SHV icon
145
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$396K 0.05%
3,588
– –
CERS icon
146
Cerus
CERS
$433M
$394K 0.05%
66,694
+9,560
+17% +$56K
BL icon
147
BlackLine
BL
$1.84B
$391K 0.05%
3,517
+481
+16% +$52.5K
BLUE
148
DELISTED
bluebird bio
BLUE
$391K 0.05%
943
+119
+14% +$47.1K
NBIX icon
149
Neurocrine Biosciences
NBIX
$16.8B
$389K 0.05%
4,000
+595
+17% +$57K
TWST icon
150
Twist Bioscience
TWST
$5.7B
$389K 0.05%
2,920
+413
+16% +$48K
4 5
6
7 8

Similar funds

AAM
Artha Asset Management Hoboken, New Jersey $90.3M AUM 27.66% 1-Year Est. Return
AEPBI
AH Equity Partners Bio III Menlo Park, California $95M AUM 50.1% 1-Year Est. Return
MW
Milestone Wealth Buffalo, New York $89.5M AUM 17.2% 1-Year Est. Return
SC
Sarissa Consulting Santa Monica, California $96.9M AUM 29.32% 1-Year Est. Return
NIM
NuWave Investment Management Parsippany, New Jersey $87.2M AUM 38.54% 1-Year Est. Return
WIM
Wilen Investment Management Bonita Springs, Florida $98.1M AUM 2.08% 1-Year Est. Return
LAM
LFS Asset Management San Ramon, California $99.1M AUM
EFEM
Eos Focused Equity Management New York $84.5M AUM 17.48% 1-Year Est. Return

Spearhead Capital Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Spearhead Capital Advisors held 195 positions worth $735M, up 8.5% from $677M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Spearhead Capital Advisors's Q2 2021 filing shows 10 new, 148 increased, 29 reduced and 4 closed positions. Its largest new stake was Golub Capital BDC: 150,000 shares worth $2.31M. The largest sale was Kiniksa Pharmaceuticals, an estimated $2.15M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Spearhead Capital Advisors's largest Q2 2021 buy was Golub Capital BDC: 150,000 shares worth $2.31M.
  • Spearhead Capital Advisors added most to Apple in Q2 2021, an estimated $1.25M increase.
  • Spearhead Capital Advisors's biggest Q2 2021 reduction was Kiniksa Pharmaceuticals, cutting an estimated $2.15M.
  • Spearhead Capital Advisors fully exited GenMark Diagnostics, Inc in Q2 2021, selling an estimated $576K.
  • Spearhead Capital Advisors's ten largest holdings make up 31% of its $735M portfolio in Q2 2021.
  • Spearhead Capital Advisors opened 10 new positions and closed 4 in Q2 2021.
  • Spearhead Capital Advisors's portfolio value rose 8.5% quarter-over-quarter to $735M.

Based on Spearhead Capital Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.